230 related articles for article (PubMed ID: 22042259)
1. The differential diagnosis between primary cutaneous large B-cell lymphoma and cutaneous follicular lymphoma: prognostic and therapeutic implications.
Fernandez-Flores A; Smucler-Simonovich A; Escalante F; Manjon JA
Am J Dermatopathol; 2011 Dec; 33(8):819-26. PubMed ID: 22042259
[TBL] [Abstract][Full Text] [Related]
2. Primary cutaneous B-cell lymphoma: subtypes, treatment and outcome of 10 cases.
Onsun N; Su O; Kural YB; Erdemoglu Y; Buyukbabani N; Demirkesen C; Aydin Y
Acta Derm Venereol; 2011 Jun; 91(4):476-8. PubMed ID: 21537819
[No Abstract] [Full Text] [Related]
3. The expression of IgM is helpful in the differentiation of primary cutaneous diffuse large B cell lymphoma and follicle center lymphoma.
Demirkesen C; Tüzüner N; Esen T; Lebe B; Ozkal S
Leuk Res; 2011 Sep; 35(9):1269-72. PubMed ID: 21700336
[TBL] [Abstract][Full Text] [Related]
4. Primary cutaneous diffuse large B-cell lymphoma, leg type: diagnostic considerations.
Hristov AC
Arch Pathol Lab Med; 2012 Aug; 136(8):876-81. PubMed ID: 22849734
[TBL] [Abstract][Full Text] [Related]
5. IgM expression on paraffin sections distinguishes primary cutaneous large B-cell lymphoma, leg type from primary cutaneous follicle center lymphoma.
Koens L; Vermeer MH; Willemze R; Jansen PM
Am J Surg Pathol; 2010 Jul; 34(7):1043-8. PubMed ID: 20551823
[TBL] [Abstract][Full Text] [Related]
6. Cutaneous telangiectasia and cauda equina syndrome: a presentation of diffuse large B-cell lymphoma.
Shim TN; El-Daly H; Carr RA; Taibjee SM; Gach JE
Am J Dermatopathol; 2013 Jun; 35(4):507-10. PubMed ID: 23694826
[TBL] [Abstract][Full Text] [Related]
7. Primary cutaneous diffuse large B-cell lymphoma, leg type: clinicopathologic features and prognostic analysis in 60 cases.
Grange F; Beylot-Barry M; Courville P; Maubec E; Bagot M; Vergier B; Souteyrand P; Machet L; Dalac S; Esteve E; Templier I; Delaporte E; Avril MF; Robert C; Dalle S; Laroche L; Delaunay M; Joly P; Wechsler J; Petrella T
Arch Dermatol; 2007 Sep; 143(9):1144-50. PubMed ID: 17875875
[TBL] [Abstract][Full Text] [Related]
8. [Complex diagnosis of follicular lymphomas].
Tóth E; Schneider T; Melegh Z; Csernák E; Udvarhelyi N; Rosta A; Szentirmay Z
Magy Onkol; 2005; 49(2):135-40. PubMed ID: 16249809
[TBL] [Abstract][Full Text] [Related]
9. Focal rituximab-induced edematous reaction at primary cutaneous follicle center lymphoma lesions: case report and literature review.
Brunet-Possenti F; Franck N; Tamburini J; Jacobelli S; Avril MF; Dupin N
Dermatology; 2011; 223(3):200-2. PubMed ID: 21986026
[TBL] [Abstract][Full Text] [Related]
10. A polycyclic annular erythematous plaque on the trunk: a quiz. Annular primary cutaneous follicle centre lymphoma.
Lemeray J; Guillot B; Dereure O
Acta Derm Venereol; 2012 Mar; 92(2):221-3. PubMed ID: 22169968
[No Abstract] [Full Text] [Related]
11. [Nodules on the legs].
Cervigón I; Mollejo M; García-Almagro D
Actas Dermosifiliogr; 2008; 99(6):485-7. PubMed ID: 18558059
[No Abstract] [Full Text] [Related]
12. MYD88 Somatic Mutation Is a Diagnostic Criterion in Primary Cutaneous Large B-Cell Lymphoma.
Menguy S; Gros A; Pham-Ledard A; Battistella M; Ortonne N; Comoz F; Balme B; Szablewski V; Lamant L; Carlotti A; Lorton MH; de Muret A; Le Gall F; Franck F; Croue A; Cappellen D; Beylot-Barry M; Merlio JP; Vergier B
J Invest Dermatol; 2016 Aug; 136(8):1741-1744. PubMed ID: 27189828
[No Abstract] [Full Text] [Related]
13. Prognostic significance of t(14;18) and bcl-2 gene expression in follicular small cleaved cell lymphoma and diffuse large cell lymphoma.
Martinka M; Comeau T; Foyle A; Anderson D; Greer W
Clin Invest Med; 1997 Dec; 20(6):364-70. PubMed ID: 9413633
[TBL] [Abstract][Full Text] [Related]
14. Reduction of tumor burden and stabilization of disease by systemic therapy with anti-CD20 antibody (rituximab) in patients with primary cutaneous B-cell lymphoma.
Heinzerling LM; Urbanek M; Funk JO; Peker S; Bleck O; Neuber K; Burg G; von Den Driesch P; Dummer R
Cancer; 2000 Oct; 89(8):1835-44. PubMed ID: 11042581
[TBL] [Abstract][Full Text] [Related]
15. Complete remission of a primary cutaneous follicle-center cell lymphoma (EORTC criteria)/diffuse large B-cell lymphoma (WHO criteria) by single first-line therapy with rituximab.
Nagasaka A; Matsue H; Kawamura T; Kanzaki M; Inozume T; Nakamura Y; Shimzu A; Shibagaki N; Yanagi M; Shimada S
J Dermatol; 2006 May; 33(5):377-9. PubMed ID: 16700675
[No Abstract] [Full Text] [Related]
16. Initial features and outcome of cutaneous and non-cutaneous primary extranodal follicular lymphoma.
Fernández de Larrea C; Martínez-Pozo A; Mercadal S; García A; Gutierrez-García G; Valera A; Ghita G; Colomo L; Gainza E; Villamor N; Nomdedeu B; Estrach T; Montserrat E; Campo E; López-Guillermo A
Br J Haematol; 2011 May; 153(3):334-40. PubMed ID: 21375524
[TBL] [Abstract][Full Text] [Related]
17. Ocular adnexal diffuse large B-cell lymphoma: local disease correlates with better outcomes.
Madge SN; McCormick A; Patel I; Hatef E; Menon V; Prabhakaran VC; Irion L; Bonshek R; Honovar S; Leatherbarrow B; Esmaeli B; Selva D
Eye (Lond); 2010 Jun; 24(6):954-61. PubMed ID: 19942938
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous B-cell lymphomas: 2015 update on diagnosis, risk-stratification, and management.
Wilcox RA
Am J Hematol; 2015 Jan; 90(1):73-6. PubMed ID: 25535037
[TBL] [Abstract][Full Text] [Related]
19. Non-Hodgkin's lymphomas involving the uterus: a clinicopathologic analysis of 26 cases.
Vang R; Medeiros LJ; Ha CS; Deavers M
Mod Pathol; 2000 Jan; 13(1):19-28. PubMed ID: 10658906
[TBL] [Abstract][Full Text] [Related]
20. [An atypical presentation of primary cutaneous diffuse B-cell lymphoma, leg type].
Brouillard C; Granel-Brocard F; Montagne K; Bastien C; Barbaud A; Schmutz JL
Ann Dermatol Venereol; 2011; 138(8-9):601-4. PubMed ID: 21893235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
